Literature DB >> 22226518

Adjuvant therapy for gastric cancer after D2 gastrectomy.

Toshirou Nishida1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22226518     DOI： 10.1016/S0140-6736(11)61928-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.

Authors:  Wuchao Li; Liwen Zhang; Chong Tian; Hui Song; Mengjie Fang; Chaoen Hu; Yali Zang; Ying Cao; Shiyuan Dai; Fang Wang; Di Dong; Rongpin Wang; Jie Tian
Journal:  Eur Radiol       Date:  2018-12-05       Impact factor: 5.315

2.  Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.

Authors:  Yuming Jiang; Tuanjie Li; Xiaoling Liang; Yanfeng Hu; Lei Huang; Zhenchen Liao; Liying Zhao; Zhen Han; Shuguang Zhu; Menglan Wang; Yangwei Xu; Xiaolong Qi; Hao Liu; Yang Yang; Jiang Yu; Wei Liu; Shirong Cai; Guoxin Li
Journal:  JAMA Surg       Date:  2017-07-19       Impact factor: 14.766

3.  The T-Cell-Inflammation Status Can Predict Outcomes of Adjuvant Chemotherapy in Patients with Gastric Cancer.

Authors:  Xiaolong Wu; Xiangyu Gao; Xiaofang Xing; Xianzi Wen; Ziyu Li; Jiafu Ji
Journal:  Ann Surg Oncol       Date:  2020-08-07       Impact factor: 5.344

4.  TIM3+ cells in gastric cancer: clinical correlates and association with immune context.

Authors:  Ke Chen; Yun Gu; Yifan Cao; Hanji Fang; Kunpeng Lv; Xin Liu; Xudong He; Jieti Wang; Chao Lin; Hao Liu; Heng Zhang; Hongyong He; Jiejie Xu; He Li; Ruochen Li
Journal:  Br J Cancer       Date:  2021-11-01       Impact factor: 7.640

5.  Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients.

Authors:  Yun Gu; Yifan Chen; Kaifeng Jin; Yifan Cao; Xin Liu; Kunpeng Lv; Xudong He; Chao Lin; Hao Liu; He Li; Hongyong He; Jing Qin; Ruochen Li; Heng Zhang; Weijuan Zhang
Journal:  Oncoimmunology       Date:  2020-11-22       Impact factor: 8.110

6.  Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer.

Authors:  Weiqiang You; Zerong Cai; Nengquan Sheng; Li Yan; Huihui Wan; Yongkun Wang; Jian Ouyang; Lu Xie; Xiaojian Wu; Zhigang Wang
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

7.  Gene expression profiles for a prognostic immunoscore in gastric cancer.

Authors:  D Zeng; R Zhou; Y Yu; Y Luo; J Zhang; H Sun; J Bin; Y Liao; J Rao; Y Zhang; W Liao
Journal:  Br J Surg       Date:  2018-04-25       Impact factor: 6.939

8.  The prognostic efficacy of the 8th edition UICC TNM classifications for gastric cancer in Chinese patients: A study based on follow-up system of nursing department.

Authors:  Liang Liu; Yu Bai; Huizi Gu; Haitao Zhu; Ying Yu; Ping Lu; Yuxi Wang; Hao Zhang; Min Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

9.  Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer.

Authors:  Puran Zhang; Yun Gu; Hanji Fang; Yifan Cao; Jieti Wang; Hao Liu; Heng Zhang; He Li; Hongyong He; Ruochen Li; Chao Lin; Jiejie Xu
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 13.751
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.